Trial Profile
An independent prospective randomised controlled trial comparing the efficacy and cost effectiveness of infliximab and etanercept in 'high need' patients with moderate to severe chronic plaque type psoriasis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Aug 2016
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Infliximab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms PIECE
- 15 Jul 2016 Results published in the British Journal of Dermatology
- 15 Jul 2016 Status changed from recruiting to completed, as per the results published in the British Journal of Dermatology.
- 17 May 2009 Status changed from planning to recruiting as reported by Netherlands Trial Register.